• Mashup Score: 2

    Ebstein anomaly (EA), a form of congenital heart disease (CHD) that occurs in 1 to 20ā€‰000 live births, consists of a distinctive malformation of the right ventricle and tricuspid valve with adherence of septal and posterior leaflets to the underlying myocardium due to failure of embryological delamination. The consequent right atrial enlargement combined with the high prevalence of accessory…

    Tweet Tweets with this article
    • RT @Heart_BMJ: Atrial fibrillation in Ebstein anomaly: weathering the storm šŸŒŖļø https://t.co/coFwuKGMsI https://t.co/tJS6pxILhv

  • Mashup Score: 3

    Ebstein anomaly (EA), a form of congenital heart disease (CHD) that occurs in 1 to 20ā€‰000 live births, consists of a distinctive malformation of the right ventricle and tricuspid valve with adherence of septal and posterior leaflets to the underlying myocardium due to failure of embryological delamination. The consequent right atrial enlargement combined with the high prevalence of accessory…

    Tweet Tweets with this article
    • Atrial fibrillation in Ebstein anomaly: weathering the storm šŸŒŖļø https://t.co/coFwuKGMsI https://t.co/tJS6pxILhv

  • Mashup Score: 9

    Objective Beta-blockers (BB) are an established treatment following myocardial infarction (MI). However, there is uncertainty as to whether BB beyond the first year of MI have a role in patients without heart failure or left ventricular systolic dysfunction (LVSD). Methods A nationwide cohort study was conducted including 43ā€‰618 patients with MI between 2005 and 2016 in the Swedish register for…

    Tweet Tweets with this article
    • RT @Heart_BMJ: Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes https://t.co/BvQQo3cl7Cā€¦

  • Mashup Score: 0

    Objective Beta-blockers (BB) are an established treatment following myocardial infarction (MI). However, there is uncertainty as to whether BB beyond the first year of MI have a role in patients without heart failure or left ventricular systolic dysfunction (LVSD). Methods A nationwide cohort study was conducted including 43ā€‰618 patients with MI between 2005 and 2016 in the Swedish register for…

    Tweet Tweets with this article
    • Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes https://t.co/BvQQo3cl7C https://t.co/m7Mcd3hsjm

  • Mashup Score: 2

    Objective There is uncertainty about surgical procedures for adult patients aged 18ā€“60 years undergoing aortic valve replacement (AVR). Options include conventional AVR (mechanical, mAVR; tissue, tAVR), the pulmonary autograft (Ross) and aortic valve neocuspidisation (Ozaki). Transcatheter treatment may be an option for selected patients. We used formal consensus methodology to make…

    Tweet Tweets with this article
    • Formal consensus study on surgery to replace the aortic valve in adults aged 18ā€“60 years https://t.co/69qlooB26X https://t.co/jRWC2LoCAA

  • Mashup Score: 5

    Coronary artery disease is a serious condition increasingly affecting young adults.1 2 Despite recent improvements in primary prevention of cardiovascular (CV) disease in older patients, identifying younger adults at risk of events who would benefit from an intensive preventive strategy remains challenging,3 even if they carry traditional, actionable cardiovascular risk factors. The Appraisal of…

    Tweet Tweets with this article
    • Lipid lowering in primary prevention: time to focus on young patients! šŸ§‘ šŸ’Š https://t.co/ejKXAZ6Xrz

  • Mashup Score: 2

    Objective Evidence on long-term costs of atrial fibrillation (AF) and associated factors is scarce. As part of the Swiss-AF prospective cohort study, we aimed to characterise AF costs and their development over time, and to assess specific patient clusters and their cost trajectories. Methods Swiss-AF enrolled 2415 patients with variable duration of AF between 2014 and 2017. Patient clusters…

    Tweet Tweets with this article
    • RT @Heart_BMJ: Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohort šŸ‡ØšŸ‡­ https://t.co/s0g9DROmdV https://t.co/mb790ā€¦

  • Mashup Score: 0

    Objective Evidence on long-term costs of atrial fibrillation (AF) and associated factors is scarce. As part of the Swiss-AF prospective cohort study, we aimed to characterise AF costs and their development over time, and to assess specific patient clusters and their cost trajectories. Methods Swiss-AF enrolled 2415 patients with variable duration of AF between 2014 and 2017. Patient clusters…

    Tweet Tweets with this article
    • Patient clusters and cost trajectories in the Swiss Atrial Fibrillation cohort šŸ‡ØšŸ‡­ https://t.co/s0g9DROmdV https://t.co/mb790mpd7w